7/24/2009

The FDA authorized Eli Lilly and Co. to promote its osteoporosis drug Forteo for treating patients who take glucocorticoid medications for rheumatoid arthritis, obstructive pulmonary disease and other inflammatory conditions. Forteo was approved in 2002 to treat osteoporosis in adults.

Full Story:
Forbes

Related Summaries